In vivo cellular kinetic and pharmacological studies of 1-beta-D-arabinofuranosylcytosine and 3-deazauridine chemotherapy for relapsing acute leukemia.
D015092:3-Deazauridine / Q000008:administration & dosage* / Q000378:metabolism; D000293:Adolescent; D000328:Adult; D000368:Aged; D002453:Cell Cycle / Q000187:drug effects; D003561:Cytarabine / Q000008:administration & dosage* / Q000378:metabolism; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D014529:Uridine / Q000031:analogs & derivatives*
D003561:Cytarabine; D015092:3-Deazauridine; D014529:Uridine